SLC18A2 and Parkinson disease: Post mortem analysis of brain tissue revealed defects in VMAT2 in synaptic vesicles from PD patients, leading to a more-than-50% reduction in vesicular uptake of dopamine into VMAT2-positive vesicles in this patient group [78].